|
⚲
|
| Keyboard |
| Inhibikase Therapeutics Inc
✚
|
|
|---|---|
| CIK # | 0001750149 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 10-K | [0001750149] | |
| 10-Q | [0001750149] | |
| 3 | [0001750149] | |
| 4 | [0001750149] | |
| 8-K | [0001750149] | |
| D | [0001750149] | |
| SC 13D | [0001750149] | |
| SC 13G | [0001750149] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Inhibikase Therapeutics Inc | |
| Aurentz Vincent | |
| Munshi Amit | |
| Berman Dennis N | |
| Canner David | |
| Kush Arvind | |
| Bellini Roberto | |
| Cabell Christopher | |
| McIntyre David | |
| Iwicki Mark T | |
| View All | |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Inhibikase Therapeutics Inc IKT
Common Stock
|
2026-02-21 | Disposed to issuer | 255,299 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Common Stock
|
2026-02-21 | Disposed to issuer | 19,089 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Common Stock
|
2026-02-21 | Disposed to issuer | 338,282 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Grant | 986,319 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Grant | 4,982,706 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2026-01-05 | Grant | 900,117 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Common Stock
|
2025-11-21 | Buy | 2,068,965 | $1.45 | 2,999,999 |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-06-30 | Grant | 108,176 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-04-14 | Grant | 1,775,539 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-02-21 | Grant | 602,346 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-02-21 | Grant | 1,100,705 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-02-21 | Grant | 134,427 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-02-17 | Grant | 1,794,291 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 39,620 | $0.00 | |
|
Inhibikase Therapeutics Inc IKT
Stock Option (Right to Buy) · derivative
|
2025-02-14 | Grant | 116,585 | $0.00 | |
| showing 20 of 143 most recent transactions | |||||